Sensus Healthcare Inc – a new Partnership for CellMark Medical this summer
Sensus Healthcare a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and CellMark Medical, a global supply chain service company, today announced a new partnership to support and accelerate international growth and encourage worldwide adoption of Sensus’ groundbreaking technologies for oncological and aesthetic indications.
Extracted from the news provided by Sensus Healthcare:
“CellMark Medical was formed to create a pathway for domestically successful, innovative medical technologies to expand from their home markets into emerging geographic locations around the world,” said Oliver Moorhouse, Head of the Americas, CellMark Medical. “As the preference is to focus on underserved clinical areas, such as skin cancer and keloids, we view Sensus Healthcare as a partner for life, and the opportunity to expedite and sustain this global growth is truly a privilege. Achieving inaugural solution commitments in international markets within six months of launching speaks volumes for the collaboration that we have developed with the Sensus management team.”
The collaboration aims to facilitate timely access for patients all over the world to Sensus’ extensive portfolio of aesthetic and dermatology solutions, including SRT and Sensus Laser Systems, as well as the Company’s future oncology solutions. CellMark Medical will leverage its proprietary trading platform and healthcare industry networks to develop sales and distribution channels in global markets, as well as work with new and existing sales partners to facilitate effective cross-border supply chain operations.
Following Sensus’ distribution deals earlier this year in China, Mexico and Thailand, among others, Sensus Healthcare and CellMark Medical will now focus on expanding distribution to Japan, Southeast Asia, Central and South Americaand Canada. The partnership has already led to the successful order of the first SRT-100 solution in Vietnam by Dr. Vu Quang Vinh, Head of the Department of Plastic and Aesthetic Reconstructive Surgery at the National Hospital of Burns in Ha Noi.
“Sensus’ collaboration with CellMark Medical offers a critical boost of support to Sensus’ international business development, which is a key priority for the Company this year,” added Rick Golin, Sensus Healthcare Executive Vice President of International Sales. “Combining Sensus’ expertise in aesthetic and dermatological solutions with CellMark Medical’s product shipping, warehousing, financing, market-specific experience and worldwide user / distributor digital CMDS system enables wider, more efficient global reach, ultimately helping to bring Sensus’ transformative technology to more patients in need all over the world.”